β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin.

Giuseppe Daniele Andrea TuraAlex BrocchiAlessandro SabaBeatrice CampiVeronica Sancho-BornezAngela Dardano Stephano Del Prato

Published in: Diabetes care (2024)

SAXA+DAPA provided superior glycemic control compared with DAPA or SAXA, with improved β-cell function, insulin sensitivity, GLP-1 availability, and glucose clearance.

Keyphrases

glycemic control
blood glucose
type diabetes
weight loss
insulin resistance
metabolic syndrome